Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | CA12 | O43570 | 2/20 | 0.52 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | CA7 | P43166 | 2/20 | 0.52 |
| ▸ | CA9 | Q16790 | 2/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | EGFR | P00533 | 3/20 | 0.45 |
| ▸ | LCK | P06239 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.43 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.43 |
| ▸ | RGS12 | O14924 | 1/20 | 0.43 |
| ▸ | CAMKK2 | Q96RR4 | 1/20 | 0.43 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7806960 | 0.89 | GABRA1 (0.43) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL3089041 | 0.86 | HSD17B1 (0.50) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL15824990 | 0.86 | GABRA1 (0.41) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL3283491 | 0.84 | HSP90AB1 (0.42) | ALDH1A1MAPTGABRA1GABRB2ESR1 | |
| SCHEMBL1920791 | 0.84 | POLB (0.41) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL28933964 | 0.84 | MEN1 (0.57) | ALDH1A1MAPTESR1ESR2MEN1 | |
| SCHEMBL278481 | 0.83 | KDM4E (0.46) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL2053985 | 0.82 | GABRA1 (0.41) | ALDH1A1TSHRMAPTGABRA1GABRB2 | |
| SCHEMBL29230369 | 0.82 | CA12 (0.56) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL2852455 | 0.81 | ALDH1A1 (0.53) | ALDH1A1TSHRPTGS2TDP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2450027-B1 | DENTAL COMPOSITIONS HAVING SPECIAL FUNCTIONALITY AND TRI-BARREL PACKAGING | KERR CORP (US) | 2023-01-11 | — | — | EP | claimed |
| WO-2020120837-A1 | ANTIMICROBIAL POLYMER COMPOSITION | PREMIX OY (FI) | 2020-06-18 | — | — | WO | claimed |
| EP-3666075-A1 | ANTIMICROBIAL POLYMER COMPOSITION | Premix Oy (FI) | 2020-06-17 | — | — | EP | claimed |
| EP-3374357-B1 | DISUBSTITUTED DIARYLOXYBENZOHETERODIAZOLE COMPOUNDS | ENI SPA (IT) | 2019-10-02 | — | — | EP | claimed |
| US-10098908-B2 | Method of treating a mammalian teat and related compositions | Zurex PharmAgra, Inc. (US) | 2018-10-16 | — | — | US | claimed |
| US-20180264080-A1 | TOPICAL APPLICATIONS OF Kv1.3 CHANNEL BLOCKING PEPTIDES TO TREAT SKIN INFLAMMATION | KINETA ONE, LLC (US) | 2018-09-20 | — | — | US | claimed |
| WO-2016112208-A2 | TOPICAL APPLICATIONS OF KV1.3 CHANNEL BLOCKING PEPTIDES TO TREAT SKIN INFLAMMATION | KINETA ONE, LLP (US) | 2016-07-14 | — | — | WO | claimed |
| US-20150250816-A1 | METHOD OF TREATING A MAMMALIAN TEAT AND RELATED COMPOSITIONS | ZUREX PHARMAGRA INC (US) | 2015-09-10 | — | — | US | claimed |
| US-20120301407-A1 | METHOD OF TREATING A MAMMALIAN TEAT AND RELATED COMPOSITIONS | Zurex PharmAgra, Inc. (US) | 2012-11-29 | — | — | US | claimed |
| US-8303821-B2 | Reduction of antimicrobial compound levels during product dispensing | ROHM AND HAAS COMPANY (US) | 2012-11-06 | — | — | US | claimed |
| WO-2006110961-A2 | NOVEL CORROSION INHIBITING MATERIALS | A J SCIENTIFIC PTY LTD (AU) | 2006-10-26 | — | — | WO | claimed |
| EP-1368016-B1 | PARENTERAL DOSAGE FORMS COMPRISING A SUSPENSION OF TRAMADOL SALT AND DICLOFENAC SALT | GRUENENTHAL GMBH (DE) | 2006-04-19 | — | — | EP | claimed |
| US-6875447-B2 | Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt | GRUNENTHAL GMBH (DE) | 2005-04-05 | — | — | US | claimed |
| US-6830782-B2 | (1) the step of activation-treatment and (2) the step of a hydrophilic polymer-treatment in this order, optionally followed by monomer grafted | KB INTERNATIONAL, LLC | 2004-12-14 | — | — | US | claimed |
| US-20030203037-A1 | Dosage forms which can be administered parenterally and comprise a suspension of the salt of tramadol and diclofenac | GRUNENTHAL GMBH (DE) | 2003-10-30 | — | — | US | claimed |
| US-20030087982-A1 | (1) the step of activation-treatment and (2) the step of a hydrophilic polymer-treatment in this order, optionally followed by monomer grafted | KB INTERNATIONAL, LLC | 2003-05-08 | — | — | US | claimed |
| EP-1164157-A1 | METHOD OF MODIFYING POLYMERIC MATERIAL AND USE THEREOF | Kanazawa, Hitoshi (JP) | 2001-12-19 | — | — | EP | claimed |
| EP-0974342-B1 | Single phase transparent aqueous composition | OREAL (FR) | 2001-09-12 | — | — | EP | claimed |
| CN-1309567-A | FSH and FSH variant formulations, products and methods | LILLY CO ELI (US) | 2001-08-22 | — | — | CN | claimed |
| EP-0126364-B1 | METABOLICALLY ACTIVE PREPARATIONS OBTAINED FROM YEAST OF ANY TYPE | HASUNOR A.G. (CH) | 1987-09-09 | — | — | EP | claimed |